Ocugen Inc (OCGN) - Rasio kapitalisasi marang bathi resik

Simbol lan logo merek Ocugen Inc (OCGN)

Ocugen, Inc. (OCGN) develops advanced biologics, optimizing component logistics through global partners to drive profit growth. Strict FDA regulations and patent protection for ophthalmological platforms ensure a high barrier to entry. The market dynamics reflected in the price action on GURU.Markets with the -4.30 indicator confirm the potential of the company, whose revenue relies on government procurement of therapies for the treatment of infections and retinal degeneration.

OCGN Ocugen Inc: Rasio rega marang bathi ing interval 04.07.2022 - 16.11.2026

Rincian metrik komprehensif lan analitis ocugen.com (OCGN)

- rega lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:Ocugen OCGN
Barang unggulan Ocugen, Inc.

Investors are seeking resilient assets, utilizing multiples to assess the market value of a business relative to its earnings. The P/E ratio measures the relationship between the current share price and earnings per share, determining the payback period for the investment. For Ocugen, Inc. (OCGN), whose gene therapies are currently in the trial stage, this calculation reflects market expectations for future breakthroughs in treating blindness. By analyzing the fundamental P/E of Ocugen, Inc. (OCGN), one can evaluate the extent of the premium paid for the potential of its long-term lifecycle.

Pesaing wigati

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|QURE - Rasio kapitalisasi marang bathi resik|Pangali P/E MGTX|Periode bali modal bisnis regenxbio.com|Pangali P/E SLDB (Solid Biosciences Inc)|Pacific Biosciences of California, Inc. (PACB) - Kapitalisasi marang bathi|BNTC - Rasio rega marang bathi|Design Pharma - Rasio rega pasar marang bathi resik|RCKT (Rocket Pharmaceuticals Inc) - Koefisien rega marang bathi|4D Molecular Therapeutics (FDMT) - Pangali P/E|Rasio rega marang bathi Lexeo Therapeutics, Inc.|Kapitalisasi marang bathi Korro Bio, Inc. KRRO|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics Corp|Rasio rega marang bathi proqr.com PRQR|CDXS - Koefisien rega marang bathi|SGMO - Rasio rega marang bathi|Rasio kapitalisasi marang bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Pangali P/E|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi